Qpex Biopharma
San Diego, California, United States · Biotechnology, Health Care, research
Qpex Biopharma, Inc., a Shionogi Group Company, is a clinical-stage biopharmaceutical company committed to improving patient care across inpatient and outpatient settings. With a robust portfolio of potential best-in-class, clinical-stage products, the company’s lead program is based on xeruborbactam, an investigational beta-lactamase inhibitor discovered by Qpex scientists. The Company recently o
Key facts
- Headquarters
- San Diego, California, United States
- Employees
- 34
- Industries
- Biotechnology, Health Care, research
- Status
- Private
- Website
- qpexbio.com
- Company page
Recent activity at Qpex Biopharma
Qpex Biopharma funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2018 | Venture | $22.1M |
Leadership
- Daniel Burgess, Director
- Kevin Li, Director
- Douglas Reed, Director
- Terry Gould, Director
- Carol Gallagher, Director
- Michael Dudley, Executive Officer, Director
- Gareth Morgan, President
Verified email and direct lines for Qpex Biopharma’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Qpex Biopharma files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Qpex Biopharma in the news
- Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists - Contagion Live (Oct 30, 2025)
- Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections - PR Newswire (Oct 22, 2018)
Companies similar to Qpex Biopharma
- Aptose Biosciences · Biotechnology, Health Care, research
- Corner Therapeutics · Biotechnology, Health Care, research
- Rezo Therapeutics · Biotechnology, Health Care, research
- Until Labs · Biotechnology, Health Care, research
- Draig Therapeutics · Biotechnology, Health Care, research
About Qpex Biopharma: questions and answers
What does Qpex Biopharma do?
Qpex Biopharma, Inc., a Shionogi Group Company, is a clinical-stage biopharmaceutical company committed to improving patient care across inpatient and outpatient settings. With a robust portfolio of potential best-in-class, clinical-stage products, the company’s lead program is based on xeruborbactam, an investigational beta-lactamase inhibitor discovered by Qpex scientists. The Company recently o
Where is Qpex Biopharma headquartered?
Qpex Biopharma is headquartered in San Diego, California, United States.
How many employees does Qpex Biopharma have?
Qpex Biopharma has about 34 employees.
Has Qpex Biopharma raised funding?
Yes. Fundz has recorded 1 funding event for Qpex Biopharma. The most recent, $22.1M, was in Oct 2018.
Who leads Qpex Biopharma?
Gareth Morgan is a President at Qpex Biopharma.
What is the latest news on Qpex Biopharma?
On Oct 15, 2025, Qpex Biopharma Appoints Gareth Morgan as President
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy